Peter McNamara, Chief Scientific Officer at Tectonic Therapeutic, Inc. (TECX), sold 172 shares at $35.00 ($6K) on 2026-06-30, disclosed to the SEC on 2026-07-01.
Scheduled sale ($6k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TECX | SELL | 2026-08-14 | $2K | — | Filing → |
| TECX | SELL | 2026-03-09 | $189K | — | Filing → |
| TECX | SELL | 2026-03-05 | $78K | — | Filing → |